Groundbreaking Covid-19 trials a boost, not bogeyman, for Africa

News

Groundbreaking Covid-19 trials a boost, not bogeyman, for Africa

The trials mean SA will have access to vaccines, which is important in the face of ‘vaccine nationalism’, say experts

Journalist

If SA is a place of contradictions, this week has been the perfect illustration.

We crossed the threshold to 100,000 confirmed cases of Covid-19 early in the week and hot on those heels came the announcement by Johannesburg’s Wits University that the continent’s first vaccine trial, for the same disease, kicks off.

On Wednesday, the first participants from Africa will be vaccinated in a local trial, carried out by Wits and the UK’s Oxford University. It forms part of a global search for a prevention against Covid-19...

This article is reserved for Times Select subscribers.
A subscription gives you full digital access to all Times Select content.

Times Select

Already subscribed? Simply sign in below.

Questions or problems?
Email helpdesk@timeslive.co.za or call 0860 52 52 00.

Next Article

Mkhize swats away criticism as SA’s Covid-19 cases sky-rocket

By Nonkululeko Njilo and Kgaugelo Masweneng
4 min read